CapBuild: a cloud-native tool for adeno-associated virus capsid engineering
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Anne H Klein und 6 weiteren Autor:innen. Beteiligte Einrichtung: Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Herston, Queensland 4006, Australia. Hauptthemen laut MEDLINE: Dependovirus, Capsid, Software, Capsid Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adeno-associated virus (AAV) capsid engineering is essential for advancing gene therapy but remains limited by structural complexity and computational constraints. To address these challenges, we developed CapBuild, a cloud-native web server that streamlines AAV capsid prediction, assembly and engineering. CapBuild provides two distinct workflows: a PDB-based pipeline for assembling complete capsids from structural files and a modelling pipeline that constructs capsids from protein sequences via SWISS-MODEL. The platform incorporates icosahedral symmetry through transformation matrices and features an integrated mutation modeller for visualising site-specific mutations across the entire capsid. Additionally, its amino acid localisation tool maps exposed and buried residues, facilitating rational design. Benchmarking against crystal structures demonstrates high structural accuracy, with consistently low RMSD values (0–0.89 Å) and high GDT scores (89.4–100%) across multiple AAV serotypes. CapBuild’s interactive visualisation interface, powered by Mol*, enables in-depth structural analysis, making capsid engineering more accessible to researchers. By reducing technical barriers and automating complex modelling tasks, CapBuild facilitates early-stage AAV capsid design, enabling researchers to rationally explore and visualise structural variants for potential use. CapBuild is available at https://capbuild.csiro.au/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Herston, Queensland 4006, Australia.
- Data 61, Commonwealth Scientific and Industrial Research Organisation, Canberra, Australian Capital Territory 2601, Australia.
- Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Canberra, Australian Capital Territory 2601, Australia.
- Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Adelaide, South Australia 5064, Australia.
- Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Westmead, Sydney 2145, Australia.
- Department of Applied BioSciences, Faculty of Science and Engineering, Macquarie University, Macquarie Park, New South Wales 2113, Australia.
ORCID-Profile: Anuradha Wickramarachchi, Denis C Bauer, Laurence Wilson
Zitieren
APA
Klein, A. H., Kuiper, M. J., Burgess, M., Wickramarachchi, A., Jain, Y., Bauer, D. C., & Wilson, L. (2025). CapBuild: a cloud-native tool for adeno-associated virus capsid engineering. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf422
Vancouver
Klein AH, Kuiper MJ, Burgess M, Wickramarachchi A, Jain Y, Bauer DC, et al. CapBuild: a cloud-native tool for adeno-associated virus capsid engineering. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf422
BibTeX
@article{Klein2025,
author = {Klein, Anne H and Kuiper, Michael J and Burgess, Mark and Wickramarachchi, Anuradha and Jain, Yatish and Bauer, Denis C and Wilson, Laurence},
title = {CapBuild: a cloud-native tool for adeno-associated virus capsid engineering},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf422}
}
EUVIMED